TLM Utility Nav

Reproductive Health and Impact on Patients with End-Stage Liver Disease

Description

Panelists in this community conversation discuss complex cases involving reproductive health and pregnancy in persons with ESLD and liver transplantation. The panel includes a patient representative, a maternal fetal medicine specialist, an obstetrician, and a hepatologist. The session consists of individual presentations addressing current evidence-based guidance/guidelines around the topic followed by an interactive panel discussion of challenging clinical scenarios. The panel reviews current American Association for the Study of Liver Diseases (AASLD) guidance and the European Association for the Study of the Liver (EASL) guidelines addressing the approach to management of pregancy in the setting of ESLD post liver transplant.



 

Presentations

9:45 AM - 10:00 AM
Nov 18 2024
San Diego, CA

The Obstetric Approach to Preconception Counseling of Individuals with End-Stage Liver Disease

Lauren D. Feld, MD, Presenter
Acute-on-Chronic Liver Failure
DEI
Hepatology Associates
10:00 AM - 10:30 AM
Nov 18 2024
San Diego, CA

Approach to Management of the Patient With End-Stage Liver, Post Liver Transplant in Pregnancy: Review of the American Association for the Study of Liver Diseases and European Association for the Study of the Liver Reproductive Health Guidance

Monika Sarkar, MD, FAASLD, MAS, Presenter
Acute-on-Chronic Liver Failure
DEI
Hepatology Associates
8:43 AM - 8:43 AM
Nov 18 2024
San Diego, CA

Panel Discussion

Maryam Tarsa, MD MAS, Panelist
Acute-on-Chronic Liver Failure
DEI
Hepatology Associates

Objectives

  • Describe the incidence, prevalence, and challenges of pregnancy in persons with ESLD.
  • Discuss the importance of reproductive health knowledge, education, and patient discussion for persons with ESLD.
  • Review evolving policy considerations and updated AASLD and EASL guidelines regarding pregnancy in the setting of liver disease.